The vascular trauma programme at […]

CX 2024: An outstanding faculty will tee up timely debates to enhance vascular education

Dittmar Böckler (Heidelberg, Germany), one of co-chairs of CX 2024, rings the CX bell, and calls out the […]

[…]

In this conversation between CX chairman Roger Greenhalgh and Professor of Vascular Surgery, Maarit Venermo (Helsinki, Finland), we discuss the importance of challenging the status quo in vascular and endovascular surgery.

Professor Venermo discusses challenging the status quo in superficial femoral artery management, non-invasive methods and her thoughts on aneurysms in the carotid artery “I’ve heard some […]

This year, we aim to reach consensus on renal interventional and vascular access issues. With the help of a world-class faculty, we will be leading a one day vascular access masterclass and workshop in London, which is the largest in Europe. We spoke with CX executive board members, Nick Inston (Birmingham, UK) and Kate Steiner […]

This year we expect over 2,500 in-person and 1,000 virtual participating vascular specialists to join us. In previous years we have hosted over 6,000 registrants virtually from over 120 countries due to the COVID-19 pandemic and are very excited to be back in London 25-27 April 2023. To make CX as accessible as possible, registrants will also have […]

Alberto Muñoz (Bogota, Colombia) talks to BLearning at CX 2019 (Charing Cross Symposium; 15–18 April, London, UK) about how the meeting provides a “great opportunity” to update attendees on the latest in vascular and endovascular surgery.

Muñoz goes on to highlight the international flavour of Charing Cross and notes the importance of the […]

Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed a significant increase in mortality […] an increased reintervention rate and four times higher endoleak rate,” […]

Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve.

Edmonds discusses why “too many legs are being lost” and Serena talks […]

Jade Hiramoto (San Francisco, USA) tells CX Live about why she believes “everyone should consider normalising glucose levels after long, complex endovascular aortic procedures—and maybe even after open thoracoabdominal aortic procedures.”

Hiramoto is presenting new research on this topic at the Charing Cross session on Spinal Cord Ischaemia in the Upper […]

Jonathan Beard, (Sheffield, UK), discusses the current medicolegal issues in the field and explains how vascular surgeons can become “the fall-guy for the inadequacies of other clinicians”. Beard touches on how the threshold for informed consent has changed “dramatically” in recent years which has led to “the death of […]

At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the value of paclitaxel devices in the treatment of peripheral arterial disease patients; examines new evidence on […]

There were several calls at the CX 2019 Highlight Session Paclitaxel: The last word on the need for a meta-analysis of individual patient-level data going forward and greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices.

Cook Medical has just announced the release of de-identifiable […]

Elena Ladich (Hollywood, USA) and Roger Greenhalgh (London, UK) discuss the current uncertainty surrounding the use of paclitaxel devices and the need for individual patient-level data analyses going forward to better understand the mortality signal raised by the Katsanos et al meta-analysis.

Ladich believes that “we need to take a step […]

In the Acute Stroke Challenges session on Monday, Nick Hopkins talks to CX Live about the “significant increase” of incidents of stroke following cardiac surgery which is “much more common than previously thought”.

Ross Naylor and Peter Schneider debated the impact of new technologies and innovations making carotid artery stenting as […]

In this interview, Meryl Davis, chair of the CX Abstract Board, talks about the benefits of presenting research at the CX Symposium and the importance of CX as a “global village”.

The CX Abstract Board is calling for senior and trainee doctors in the vascular and endovascular field to submit their […]

This year, CX celebrates 40 Years of Looking Forward. In this video, members of the CX Programme Organising Board and the CX Faculty explain why CX is not only unique but also provides vascular education “as it should be”! Register now for CX 2018!

[…]

Lowell Kabnick (New York, United States), who is a CX Faculty member, describes how the CX Venous Workshop has gone from being a small intimate session to one that, while still intimate, is “really large and all inclusive”. He adds that he believes that it is the best he has seen.

[…]

Meryl Davis, member of the CX Abstracts Board, talks about the invaluable opportunity for senior and trainee vascular and endovascular clinicians to present at the CX Abstract sessions.

Pasha Normahani (Imperial Vascular Unit, Imperial Academic Health Science Centre, London, UK) has been an attendee at the Charing Cross (CX) Symposium for over seven years. In 2016, he presented for the first time at the CX Abstract sessions and was awarded with a Certificate of Merit for his research in peripheral arterial disease. In […]

Ian Loftus, Co-chairman CX Abstract Board, reviews the highlights of this year’s CX Abstract Presentations session. He emphasises the quality of the work submitted and how relevant it is for young and senior clinicians to present their research at the Charing Cross Symposium.

“The Peripheral Arterial Programme at the Charing Cross Symposium in 2016 is really exciting; it combines the hot topics in the field with evidence, opinion and discussion,” says Andrew Holden (Auckland, New Zealand), member of the CX Programme Organising Board. He overviews key areas to be discussed on Tuesday 26 April including the management of […]

In 2016, the Charing Cross Venous Programme will run on the four days of the Symposium (26–29 April) with the Main Programme for the first time on day 1, followed by the CX Venous Workshop on days 2 and 3, and the CX Venous Abstract Presentations on day 4. Ian Franklin (London, UK), member of […]

Stephen Black (London, UK), member of the CX Programme Organising Board, discusses the highlights of this year’s Deep Venous section of the CX Venous Challenges Day.

“There has never been a more exciting expectation of what we have for this year in the aortic area at CX,” says Roger Greenhalgh, chairman of the CX Programme Organising Board. Results from the Individual Patient Data meta-analysis of the four randomised controlled trials on endovascular aneurysm repair against open repair (EVAR 1, DREAM, OVER […]